[Risk factors for parenteral nutrition-associated cholestasis in preterm infants]

Yan-Hua Li1, Xin-Li Wang

  • 1Department of Pediatrics, Peking University Third Hospital, Beijing, China.

Insights

Parenteral nutrition-associated cholestasis (PNAC) in preterm infants is linked to longer PN duration, higher nutrient intake, low birth weight, and infections. Identifying these risk factors is crucial for infant health.

Area of Science:

  • Neonatology
  • Pediatric Gastroenterology
  • Nutritional Science

Context:

  • Parenteral nutrition (PN) is essential for preterm infants unable to feed enterally.
  • Parenteral nutrition-associated cholestasis (PNAC) is a significant complication in this vulnerable population.
  • Understanding PNAC risk factors is critical for optimizing infant outcomes.

Purpose:

  • To identify key risk factors associated with the development of PNAC in preterm infants.
  • To analyze the relationship between PN delivery parameters and PNAC incidence.
  • To provide data for the prevention and management of PNAC.

Summary:

  • A case-control study of 244 preterm infants revealed that longer PN duration, higher total and maximum daily amino acid and lipid intake, increased day 14 intravenous calorie intake, low birth weight, neonatal infection, and anemia were significantly associated with PNAC.
  • Infants without PNAC showed different associations between nutrient intake, PN duration, mechanical ventilation, and gestational age, highlighting complex interactions.
  • These findings underscore the multifactorial nature of PNAC in preterm neonates.

Impact:

  • Informs clinical practice regarding PN management in preterm infants to mitigate PNAC risk.
  • Highlights the need for careful monitoring of nutritional intake and clinical status in infants receiving prolonged PN.
  • Suggests areas for future research into novel preventative strategies for PNAC.
Abstract

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
2.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
963
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
552
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
29
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
26